Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Ann Thorac Surg ; 72(6): 1945-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11789776

ABSTRACT

BACKGROUND: Cimetidine, which is usually used for gastric ulcer, enhances cellular immunity. The effect of cimetidine on perioperative proinflammatory response after cardiac surgery with cardiopulmonary bypass was investigated. METHODS: Elective coronary artery bypass graft cases in which CPB was performed were placed randomly in a cimetidine (C) group (n = 20) or a no-treatment (N) group (n = 20). The time course of plasma levels of neutrophil elastase, interleukin (IL)-6 and IL-8, leukocyte counts, lymphocyte recovery ratio, C-reactive protein, creatine-kinase-MB, and oxygenation index were analyzed. RESULTS: The plasma levels of neutrophil elastase and IL-8 were inhibited in the C groups at 2 hours after CPB termination. In a comparison of the two groups, the C group demonstrated higher lymphocyte recovery ratio and lower C-reactive protein on postoperative day 5 and shorter intubation time. No intergroup differences were observed in IL-6, leukocyte counts, creatine-kinase-MB levels, or oxygenation index. CONCLUSIONS: Cimetidine may reduce surgical stress and augment the immune system after cardiac surgery with cardiopulmonary bypass.


Subject(s)
Cardiopulmonary Bypass , Cimetidine/administration & dosage , Coronary Artery Bypass , Postoperative Complications/prevention & control , Systemic Inflammatory Response Syndrome/prevention & control , Aged , C-Reactive Protein/metabolism , Cimetidine/adverse effects , Dose-Response Relationship, Drug , Female , Humans , Interleukin-6/blood , Interleukin-8/antagonists & inhibitors , Interleukin-8/blood , Leukocyte Count , Leukocyte Elastase/antagonists & inhibitors , Leukocyte Elastase/blood , Lymphocyte Count , Male , Middle Aged , Postoperative Complications/immunology , Systemic Inflammatory Response Syndrome/immunology
2.
Ann Thorac Surg ; 71(6): 1931-8, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11426771

ABSTRACT

BACKGROUND: To evaluate the effects of colforsin daropate hydrochloride (colforsin), a water-soluble forskolin derivative, on hemodynamics and systemic inflammatory response after cardiopulmonary bypass, we conducted a prospective randomized study. METHODS: Twenty-nine patients undergoing coronary artery bypass grafting were randomized to receive either colforsin treatment (colforsin; n = 14) or no colforsin treatment (control; n = 15). Administration of colforsin (0.5 microg.kg(-1).min(-1)) was started after induction of anesthesia and was continued for 6 hours. Perioperative cytokine and cyclic adenosine monophosphate levels, hemodynamics, and respiratory function were measured serially. RESULTS: Marked positive inotropic and vasodilatory effects were observed in patients receiving colforsin. Interleukin 1beta, interleukin 6, and interleukin 8 levels after cardiopulmonary bypass were significantly (p < 0.05) lower in the colforsin group. Plasma levels of cyclic adenosine monophosphate increased significantly (p < 0.05) in the colforsin group, and the levels correlated inversely (r = -0.56, p = 0.002) with the respiratory index after cardiopulmonary bypass. CONCLUSIONS: Intraoperative administration of colforsin daropate hydrochloride had potent inotropic and vasodilatory activity and attenuated cytokine production and respiratory dysfunction after cardiopulmonary bypass. The results indicate that the technique can be a novel therapeutic strategy for the systemic inflammatory response associated with cardiopulmonary bypass.


Subject(s)
Cardiotonic Agents/administration & dosage , Colforsin/analogs & derivatives , Colforsin/administration & dosage , Coronary Artery Bypass , Postoperative Complications/drug therapy , Premedication , Systemic Inflammatory Response Syndrome/drug therapy , Aged , Cardiopulmonary Bypass , Cardiotonic Agents/adverse effects , Colforsin/adverse effects , Female , Humans , Interleukin-1/blood , Interleukin-6/blood , Interleukin-8/blood , Male , Middle Aged , Myocardial Contraction/drug effects , Postoperative Complications/immunology , Prospective Studies , Systemic Inflammatory Response Syndrome/immunology , Vasodilation/drug effects
3.
J Heart Valve Dis ; 10(4): 542-4, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11499604

ABSTRACT

A 77-year-old man had a large right atrial (RA) thrombus associated with a combined mitral and tricuspid valve disease. Echocardiography showed a large, immobile, non-homogeneous, irregularly surfaced mass in the dilated RA, and prolapse of the anterior mitral leaflet resulting in massive mitral regurgitation. Computed tomography (CT) revealed a laminated structure with calcification and distinct margins, without invasion to the wall of the RA. On the basis of these echocardiographic and CT findings, a diagnosis of combined mitral and tricuspid valvular disease complicated with RA thrombus was made. Removal of the RA thrombus, mitral valve replacement and tricuspid annuloplasty were performed simultaneously, with successful outcome.


Subject(s)
Heart Atria , Heart Valve Diseases/complications , Thrombosis/complications , Aged , Heart Atria/diagnostic imaging , Heart Atria/pathology , Heart Atria/surgery , Heart Valve Diseases/diagnostic imaging , Heart Valve Diseases/surgery , Humans , Male , Mitral Valve Insufficiency/complications , Mitral Valve Prolapse/complications , Tricuspid Valve Insufficiency/complications , Ultrasonography
4.
J Cardiovasc Surg (Torino) ; 43(5): 661-3, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12386580

ABSTRACT

Pulmonary artery aneurysm (PAA) is a rare condition, and its pathogenesis and clinical significance are not clearly understood. Although reports of this condition have increased, PAAs developed in a family have never been reported. We describe PAA associated with atrial septal defect in a mother and daughter. A PAA in the mother was treated by pulmonary root replacement with a Freestyle aortic root bioprosthesis. A PAA in the daughter has been followed up because of a small shunt through the defect. In addition to the increased pulmonary blood flow, congenital weakness of the PA wall must have contributed to development of PAAs in our patients.


Subject(s)
Aneurysm/genetics , Heart Septal Defects, Atrial/genetics , Pulmonary Artery , Aneurysm/diagnostic imaging , Aneurysm/etiology , Female , Heart Septal Defects, Atrial/complications , Humans , Middle Aged , Tomography, X-Ray Computed
5.
Kyobu Geka ; 54(5): 391-5, 2001 May.
Article in Japanese | MEDLINE | ID: mdl-11357303

ABSTRACT

The effects of Adehl, colforsin daropate hydrochloride, on hemodynamics were studied in patients undergoing cardiac surgery. Twenty-six patients who underwent coronary artery bypass grafting were divided into two groups according to the intraoperative administration of Adehl. The control group (n = 14) received no Adehl treatment and the Adehl group (n = 12) received Adehl infusion immediately after anesthesia induction (0.5 microgram.kg-1.min-1) for 6 hours. Hemodynamic measurements and clinical results were accessed perioperatively. The Adehl group resulted in significantly (p < 0.05) lower pulmonary capillary wedge pressure and systemic vascular resistance, and significantly (p < 0.05) greater cardiac indices and left ventricular stroke work indices than those in the control group. No significant difference was found in the rate pressure product between the groups. The Adehl group resulted in significantly shorter duration of intubation and ICU stay. Adehl was not associated with a significant increase in the prevalence of adverse effects. The results suggest that Adehl has positive inotropic and vasodilator effects without increasing myocardial oxygen consumption. Thus, it is suggested that Adehl can be a useful agent for the perioperative management in patients undergoing cardiac surgery.


Subject(s)
Colforsin/analogs & derivatives , Colforsin/therapeutic use , Coronary Artery Bypass , Coronary Disease/surgery , Hemodynamics/physiology , Vasodilator Agents/therapeutic use , Aged , Coronary Disease/physiopathology , Female , Humans , Male , Middle Aged
6.
Jpn Circ J ; 65(6): 581-3, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11407746

ABSTRACT

Rupture of the posterior wall of the left ventricle after mitral valve replacement is a dire complication associated with a very high mortality. This study reports a successful repair of type I left ventricular rupture, which occurred after mitral valve replacement concomitant with a left atrial reduction procedure, by combination of an intracardiac patch and an extracardiac buttress suture. In a case such as this, in which hemostasis is quite difficult to establish, this combination technique is particularly effective.


Subject(s)
Heart Rupture/surgery , Heart Valve Prosthesis Implantation/adverse effects , Female , Heart Atria/surgery , Heart Rupture/etiology , Heart Ventricles/injuries , Heart Ventricles/surgery , Humans , Middle Aged , Mitral Valve Stenosis/complications , Mitral Valve Stenosis/surgery , Sutures
7.
Jpn Circ J ; 65(4): 257-60, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11316118

ABSTRACT

A more durable mechanical valve may be a better choice for the tricuspid position than a bioprosthesis when the patient already has mechanical prosthesis in the left side of the heart. Eleven cases of triple valve replacement (total follow-up period, 49.5 patient years), all with mechanical valves, are reviewed to assess optimal valve selection. Nine patients had undergone a total of 12 previous cardiac surgeries. Three patients died in hospital (27.3%), but there were no late deaths among the survivors. Two cases of valve thrombosis in the tricuspid position occurred (linearized incidence: 4.04%/patient years) and 1 of these required reoperation. Because of this high incidence of valve thrombosis, the bileaflet mechanical valve is not considered to be the best choice. Even if mechanical valves are implanted in the left side of the heart, a bioprosthesis may be a better choice at the tricuspid position.


Subject(s)
Heart Valve Prosthesis , Tricuspid Valve/surgery , Adult , Aged , Aortic Valve , Cardiac Output, Low/mortality , Endocarditis, Bacterial/mortality , Female , Follow-Up Studies , Heart Valve Prosthesis Implantation/methods , Hemodynamics , Humans , Male , Middle Aged , Mitral Valve , Multiple Organ Failure/mortality , Postoperative Complications/mortality , Prosthesis Design , Prosthesis Failure , Prosthesis-Related Infections/mortality , Reoperation , Thrombosis/epidemiology , Treatment Outcome
8.
Jpn Circ J ; 65(1): 28-32, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11153818

ABSTRACT

UNLABELLED: It is well known that dialysis-dependent renal failure increases the likelihood of a poor outcome following cardiac surgery. However, it is not known whether non-dialysis-dependent mild renal insufficiency also influences clinical outcome. Fifty-five patients with non-dialysis-dependent renal insufficiency undergoing coronary artery bypass grafting (CABG) (Renal group: serum creatinine level >1.5 mg/dl) were enrolled. These patients were then matched on prognostic variables to 148 patients with normal renal function ( CONTROL GROUP: serum creatinine level <1.5 mg/dl). The early postoperative clinical results showed that patients in the Renal group were more likely to develop postoperative renal failure (18% vs 1%: p=0.0002) and hemorrhage requiring re-exploration (11% vs 2%; p=0.01). Total morbidity was significantly higher in the Renal group (40% vs 22%; p=0.01). Multivariate analysis revealed that the Renal group was the second most important predictor of morbidity (odds ratio (OR) =2.2) behind left ventricular dysfunction (OR=2.9). The Renal group was also the second most important predictor of postoperative renal failure (OR=12.5). Therefore, non-dialysis-dependent mild renal insufficiency also increases the risk of morbidity following CABG.


Subject(s)
Coronary Artery Bypass/adverse effects , Renal Insufficiency/complications , Aged , Coronary Artery Bypass/mortality , Female , Hemorrhage/etiology , Humans , Male , Middle Aged , Morbidity , Multivariate Analysis , Postoperative Complications/etiology , Postoperative Complications/mortality , Prognosis , Renal Insufficiency/epidemiology , Renal Insufficiency/etiology , Renal Insufficiency/surgery , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL